687 related articles for article (PubMed ID: 12853682)
1. The course of genetically determined chronic pancreatitis.
Keim V; Witt H; Bauer N; Bodeker H; Rosendahl J; Teich N; Mossner J
JOP; 2003 Jul; 4(4):146-54. PubMed ID: 12853682
[TBL] [Abstract][Full Text] [Related]
2. Screening for human cationic trypsinogen (PRSS1) and trypsinogen inhibitor gene (SPINK1) mutations in a Finnish family with hereditary pancreatitis.
Räty S; Piironen A; Babu M; Pelli H; Sand J; Uotila S; Nordback I; Herzig KH
Scand J Gastroenterol; 2007 Aug; 42(8):1000-5. PubMed ID: 17613931
[TBL] [Abstract][Full Text] [Related]
3. CFTR, PRSS1 and SPINK1 mutations in the development of pancreatitis in Brazilian patients.
Bernardino AL; Guarita DR; Mott CB; Pedroso MR; Machado MC; Laudanna AA; Tani CM; Almeida FL; Zatz M
JOP; 2003 Sep; 4(5):169-77. PubMed ID: 14526128
[TBL] [Abstract][Full Text] [Related]
4. Cationic trypsinogen mutations and pancreatitis.
Howes N; Greenhalf W; Stocken DD; Neoptolemos JP
Gastroenterol Clin North Am; 2004 Dec; 33(4):767-87. PubMed ID: 15528017
[TBL] [Abstract][Full Text] [Related]
5. Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis.
Drenth JP; te Morsche R; Jansen JB
Gut; 2002 May; 50(5):687-92. PubMed ID: 11950817
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the serine protease inhibitor, Kazal type 1 gene, in patients with idiopathic chronic pancreatitis.
Truninger K; Witt H; Köck J; Kage A; Seifert B; Ammann RW; Blum HE; Becker M
Am J Gastroenterol; 2002 May; 97(5):1133-7. PubMed ID: 12014716
[TBL] [Abstract][Full Text] [Related]
7. Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis.
Chandak GR; Idris MM; Reddy DN; Mani KR; Bhaskar S; Rao GV; Singh L
Gut; 2004 May; 53(5):723-8. PubMed ID: 15082592
[TBL] [Abstract][Full Text] [Related]
8. Analysis of CFTR, SPINK1, PRSS1 and AAT mutations in children with acute or chronic pancreatitis.
Sobczyńska-Tomaszewska A; Bak D; Oralewska B; Oracz G; Norek A; Czerska K; Mazurczak T; Teisseyre M; Socha J; Zagulski M; Bal J
J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):299-306. PubMed ID: 16954950
[TBL] [Abstract][Full Text] [Related]
9. Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants.
Teich N; Bauer N; Mössner J; Keim V
Am J Gastroenterol; 2002 Feb; 97(2):341-6. PubMed ID: 11866271
[TBL] [Abstract][Full Text] [Related]
10. Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene.
Felderbauer P; Karakas E; Fendrich V; Bulut K; Horn T; Lebert R; Holland-Letz T; Schmitz F; Bartsch D; Schmidt WE
Am J Gastroenterol; 2008 Feb; 103(2):368-74. PubMed ID: 18076731
[TBL] [Abstract][Full Text] [Related]
11. Serine protease inhibitor Kazal type 1 mutations and pancreatitis.
Schneider A
Gastroenterol Clin North Am; 2004 Dec; 33(4):789-806. PubMed ID: 15528018
[TBL] [Abstract][Full Text] [Related]
12. Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis.
Keiles S; Kammesheidt A
Pancreas; 2006 Oct; 33(3):221-7. PubMed ID: 17003641
[TBL] [Abstract][Full Text] [Related]
13. Genetic aspects of chronic pancreatitis: insights into aetiopathogenesis and clinical implications.
Truninger K; Ammann RW; Blum HE; Witt H
Swiss Med Wkly; 2001 Oct; 131(39-40):565-74. PubMed ID: 11775491
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis.
Witt H; Luck W; Hennies HC; Classen M; Kage A; Lass U; Landt O; Becker M
Nat Genet; 2000 Jun; 25(2):213-6. PubMed ID: 10835640
[TBL] [Abstract][Full Text] [Related]
15. Cationic trypsinogen mutations and pancreatitis.
Howes N; Greenhalf W; Stocken DD; Neoptolemos JP
Clin Lab Med; 2005 Mar; 25(1):39-59. PubMed ID: 15749231
[TBL] [Abstract][Full Text] [Related]
16. A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1 mutations.
Felderbauer P; Hoffmann P; Einwächter H; Bulut K; Ansorge N; Schmitz F; Schmidt WE
BMC Gastroenterol; 2003 Nov; 3():34. PubMed ID: 14641934
[TBL] [Abstract][Full Text] [Related]
17. Contribution of the CFTR gene, the pancreatic secretory trypsin inhibitor gene (SPINK1) and the cationic trypsinogen gene (PRSS1) to the etiology of recurrent pancreatitis.
Tzetis M; Kaliakatsos M; Fotoulaki M; Papatheodorou A; Doudounakis S; Tsezou A; Makrythanasis P; Kanavakis E; Nousia-Arvanitakis S
Clin Genet; 2007 May; 71(5):451-7. PubMed ID: 17489851
[TBL] [Abstract][Full Text] [Related]
18. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).
Teich N; Le Maréchal C; Kukor Z; Caca K; Witzigmann H; Chen JM; Tóth M; Mössner J; Keim V; Férec C; Sahin-Tóth M
Hum Mutat; 2004 Jan; 23(1):22-31. PubMed ID: 14695529
[TBL] [Abstract][Full Text] [Related]
19. Genetic prevalence and characteristics in children with recurrent pancreatitis.
Sultan M; Werlin S; Venkatasubramani N
J Pediatr Gastroenterol Nutr; 2012 May; 54(5):645-50. PubMed ID: 22094894
[TBL] [Abstract][Full Text] [Related]
20. The SPINK1 N34S mutation is not associated with Type 2 diabetes mellitus in a population of the USA.
Schneider A; Lawrence EC; Barmada MM; Norris JM; Hamman RF; Marshall JA; Ferrell RE; Whitcomb DC
Diabet Med; 2005 Jun; 22(6):744-8. PubMed ID: 15910626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
